American Regent is conducting a nationwide voluntary recall of multiple lots of vasopressin injection because some vials may not maintain potency throughout their shelf-life. Potential adverse events after administration of solutions that are below potency limits may include reduced effectiveness. Healthcare facilities and providers that have the recalled products in their possession should immediately quarantine any product for return to American Regent. A full listing of the recalled lots is available at www.fda.gov/Safety/Recalls/ucm266615.htm.
Vasopressin injection is indicated for the prevention and treatment of postoperative abdominal distention, in abdominal roentgenography to dispel interfering gas shadows, and in diabetes insipidus.
For more information visit www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm266648.htm.